Loading…

ApoE [var epsilon]4 genotype and the age at onset of temporal lobe epilepsy: A case-control study and meta-analysis

In order to investigate the role of ApoE [var epsilon]4 as a modifier of the age at onset of temporal lobe epilepsy (TLE), we performed a molecular epidemiology study in 78 patients with mesial temporal lobe epilepsy and hippocampal sclerosis. Genotyping was done by a PCR-RFLP assay. In order to bet...

Full description

Saved in:
Bibliographic Details
Published in:Epilepsy research 2010-08, Vol.90 (3), p.234-239
Main Authors: Kauffman, Marcelo Andres, Consalvo, Damian, Moron, Dolores Gonzalez, Lereis, Virginia Pujol, Kochen, Silvia
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In order to investigate the role of ApoE [var epsilon]4 as a modifier of the age at onset of temporal lobe epilepsy (TLE), we performed a molecular epidemiology study in 78 patients with mesial temporal lobe epilepsy and hippocampal sclerosis. Genotyping was done by a PCR-RFLP assay. In order to better estimate the role of this variant as a modifier of the age at onset, we also performed a systematic review of the literature. We included our results into a meta-analysis along with data available from seven published studies with 728 patients that looked into the role of ApoE [var epsilon]4 in TLE. We found that ApoE [var epsilon]4 carriers in our population had a non-significant earlier age of epilepsy onset than non-carriers. The meta-analysis confirmed this finding, showing that ApoE [var epsilon]4 carriers had epilepsy onset almost 4 years earlier than non-carriers (mean difference 5.15 years; CI 95% 2.08-6.22; p = 0.001). In conclusion, the ApoE [var epsilon]4 isoform is a genetic factor that might influence the age at onset of TLE.
ISSN:0920-1211
DOI:10.1016/j.eplepsyres.2010.05.007